María Consuelo López-Berges-rekin lankidetzan egindako argitalpenak (47)

2011

  1. The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis

    Blood, Vol. 117, Núm. 13, pp. 3613-3616

2010

  1. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. 4, pp. 239-252

2009

  1. Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT

    CLINICAL LYMPHOMA & MYELOMA

  2. The Presence of Normal PC at Diagnosis by Flow Cytometry is a Favorable Prognostic Feature in MM

    CLINICAL LYMPHOMA & MYELOMA

  3. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients

    Blood, Vol. 114, Núm. 20, pp. 4369-4372

2008

  1. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

    Blood, Vol. 112, Núm. 10, pp. 4017-4023

2007

  1. Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia

    Clinical Lymphoma and Myeloma, Vol. 7, Núm. 9, pp. 573-579

2005

  1. Cell cycle analysis of Waldenström's macroglobulinemia

    Clinical Lymphoma, Vol. 5, Núm. 4, pp. 250-252

  2. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells

    Haematologica, Vol. 90, Núm. 1, pp. 54-59

  3. Genetic abnormalities and patterns of antigenic expression in multiple myeloma

    Clinical Cancer Research, Vol. 11, Núm. 10, pp. 3661-3667

  4. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: Impact on the clinical, biological and immunophenotypical disease characteristics

    Leukemia, Vol. 19, Núm. 5, pp. 713-720

2004

  1. CD34 + cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance - Associated phenotypes

    Clinical Cancer Research, Vol. 10, Núm. 22, pp. 7599-7606

  2. Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34- bone marrow cell compartments from patients with myelodysplastic syndromes [3]

    Leukemia

  3. Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients

    International Journal of Cancer, Vol. 112, Núm. 5, pp. 884-889

2003

  1. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone

    Blood, Vol. 102, Núm. 8, pp. 2994-3002

  2. Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: Early immunophenotypic evaluation has high clinical value

    Blood, Vol. 101, Núm. 12, pp. 4695-4700

2002

  1. Incidence of phenotypic aberrations in series of 467 patients with B chronic lymphoproliferative disorders: Basis for the design of specific four-color stainings to be used for minimal residual disease investigation

    Leukemia, Vol. 16, Núm. 8, pp. 1460-1469

2001

  1. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression

    Leukemia, Vol. 15, Núm. 3, pp. 406-414

1999

  1. An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia

    Communications in Clinical Cytometry, Vol. 38, Núm. 2, pp. 70-75

  2. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705